News and Comments


  Wednesday, April 28, 2010

Despite the emergence of new biological treatments for cancer, Chemotherapy is still essential, and indispensable as a major treatment for malignancies. The adverse events caused by these chemicals were found to be acceptable as a risk versus the great reward of using chemotherapy. The technological evolution that took place in the past decade and the surfacing of state-of-the-art technologies such as nanotechnology, scientists believed possibilities exist now for improving the adverse effect profiles of these therapeutic molecules. Reformulating the existing products has become an increasingly common product lifecycle-management technique. We read that a 2004 report on the U.S. drug market from BCC, Inc. projected that reformulations would grow from 62% of the market in 2003 to 79% in 2008. Finding ways to modify and improve existing products’ side effect profiles has become feasible after being essential but unreachable goal.  More...

Recent Postings



Cytokinetics (CYTK) Spike Therapeutics (ONCE) Illumina (ILMN) HALOZYME (HALO) Prolor Biotech (PBTH) IDERA (IDRA) REGULUS (RGLS) Sangamo (SGMO) ABBVIE (ABBV) Rapamune Intercept (ICPT) KITE (KITE) Telaprevir Roche (RHHBY) Zerenex Global Cell Therapeutics (GBT) Theravance (THRX) ImmunoGen (IMGN) Roche (ROCHE) Human Longevity (HLI) Dendreon (DNDN) C4 Therapeutics AERIE PHARMACEUTICALS SUNESIS PHARMACEUTICALS (SNSS) Biocryst (BCRX) Genentech Amgen (AMGN) OSI (OSIP) Sanofi (SNA) Auspex (ASPX) Tysabri NEKTAR (NKTR)) Micromet (MITI) Idenix (IDIX) Anadys (ANDS) Vertex (VRTX) Ziofpharm (ZIOP) Mirati Therapeutics (MRTX) Bristol-Myers Squibb (BMY) Theravance Bio Pharma (TBPH) Multiple Myeloma Ariad (ARIA) Valeant Pharmaceuticals International (VRX) Merck (MRK) Biogen Idec (BIIB) Alder Biopharmaceuticals (ALDR) Intrexon (XON) ISIS (ISIS) Ionis (IONS) Onyx (ONXX) TOKAI (TKAOI) Agenus (AGEN ZALTRAP™ Velcade (bortezomib) Sequenom (SQNM) GlaxoSmithKline (GSK) NANTKWEST (NK) Alnylam (ALNY) SYNTA (SNTA) Seattle Genetics (SGEN) Sanofi-Aventis (SAN) Intermune (ITMN) AGOS (ARGS) Editas (EDIT) Sarepta (SRPT) KERYX (KERX) Anacor (ANAC) CompuGen (CGEN) Sanofi (SNY) Dynavax (DVAX) Gilead (GILD) RenenxBio (RGNX) Aimmune Therapeutics (AIMT) Inovio (INO) Vitae Pharmaceuticals (VTAE) Human Genome Sciences (HGSI) Endometrial Cancer Ridaforolimus Pluristem (PSTI) Array Pharmaceuticals (ARRY) Trastuzumab-DM1 Benlysta (belimumab) JUNO (JUNO) Revlimid (lenolidamide) Herceptin Jazz Pharmaceuticals (JAZZ) Galena (GALE) Exelixis (EXEL) GUARDIAN HEALTH Regeneron (REGN) BIOMARIN (BMRN) INNOVIVA (INVA) Elan (ELN) Xoma (XOMA) ARCA (ABIO) galapagos (GLPG) Prosensa (RNA) Incyte (INCY) Agenus (AGEN) SERES THERAPEUTICS (MCRB) PTC Therapeutics (PTCT) VANDA (VNDA) ARGOS (ARGS) ADVENTRIX (ANX) ACADIA (ACAD) Abbott Laboratories (ABT)